Lastly, CAPG was significantly elevated in VIVA1 cells and has recently been shown to promote breast cancer metastasis via its ability to influence epigenetic modifications in cancer cells [67] and was prognostic for development of metastasis in adjuvant-treated breast cancer patients [68]. This evidence concerns the gene CAPG and breast carcinoma.